NF-κB Inhibitor (trifluoroacetate salt) (Synonyms: SN50 Peptide) |
|
Catalog No.GC48985
|
A cell-permeable peptide that blocks nuclear import of NF-κB
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: N/A
Sample solution is provided at 25 µL, 10mM.
NF-κB inhibitor is a synthetic peptide corresponding to the nuclear localization sequence of NF-κB p105 subunit (also known as p50) appended to a hydrophobic sequence to facilitate import into living cells.1 It blocks the nuclear import of p105 in cells treated with activators of NF-κB signaling, including LPS and TNF-α.1 In this way, NF-κB inhibitor blocks gene expression that is regulated by NF-κB.2,3 This peptide is commonly used to evaluate the role of NF-κB signaling in cellular responses.4,5
1.Lin, Y.Z., Tao, S., Veach, R.A., et al.Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequenceJ. Biol. Chem.270(24)14255-14258(1995) 2.Torgerson, T.R., Colosia, A.D., Donahue, J.P., et al.Regulation of NF-κB, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-κB p50Journal of Immunology161(11)6084-6092(1998) 3.Kasibhatla, S., Genestier, L., and Green, D.R.Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κBThe Journal of Biological Chemisty274(2)987-992(1999) 4.Methot, L., Hermann, R., Tang, Y., et al.Interaction and antagonistic roles of NF-κB and Hes6 in the regulation of cortical neurogenesisMolecular and Cellular Biology33(14)2797-2808(2013) 5.WÄster, P., Rosdahl, I., and Ölinger, K.Cell fate regulated by nuclear factor-κB- and activator protein-1-dependent signalling in human melanocytes exposed to ultraviolet A and ultraviolet BBritish Journal of Dermatology171(6)1336-1346(2014)
| Cas No. | N/A | SDF | |
| Synonyms | SN50 Peptide | ||
| Canonical SMILES | [H]N[C@H](C(N[C@H](C(N[C@@H](C(C)C)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N1CCC[C@H]1C(N[C@H](C(N[C@@H](C(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@H](C(N2CCC[C@H]2C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@H](C(N3CCC[C@H]3C(O)=O)=O)CCSC)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C)=O)=O)=O)C)=O)=O)=O)=O)C)=O)=O)=O)=O)C)=O)=O)C)=O)C.OC(C(F)(F)F)=O | ||
| Formula | C129H230N36O29S·XCF3COOH | M.Wt | 2781.5 |
| Solubility | DMF: 30 mg/ml,DMSO: 30 mg/ml,Ethanol: 50 mg/ml,PBS (pH 7.2): 5 mg/ml | Storage | -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 359.5 μL | 1.7976 mL | 3.5952 mL |
| 5 mM | 71.9 μL | 359.5 μL | 719 μL |
| 10 mM | 36 μL | 179.8 μL | 359.5 μL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >95.00% Appearance: A crystalline solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 14 reference(s) in Google Scholar.)















